160 related articles for article (PubMed ID: 23805828)
1. Brimonidine protects against loss of Thy-1 promoter activation following optic nerve crush.
Dai Y; Lindsey JD; Duong-Polk KX; Chindasub P; Leung CK; Weinreb RN
BMC Ophthalmol; 2013 Jun; 13(1):26. PubMed ID: 23805828
[TBL] [Abstract][Full Text] [Related]
2. Protection by an oral disubstituted hydroxylamine derivative against loss of retinal ganglion cell differentiation following optic nerve crush.
Lindsey JD; Duong-Polk KX; Dai Y; Nguyen DH; Leung CK; Weinreb RN
PLoS One; 2013; 8(8):e65966. PubMed ID: 23940507
[TBL] [Abstract][Full Text] [Related]
3. Differential protection of injured retinal ganglion cell dendrites by brimonidine.
Lindsey JD; Duong-Polk KX; Hammond D; Chindasub P; Leung CK; Weinreb RN
Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1789-804. PubMed ID: 25634981
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of histone deacetylases 1 and 3 protects injured retinal ganglion cells.
Chindasub P; Lindsey JD; Duong-Polk K; Leung CK; Weinreb RN
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):96-102. PubMed ID: 23197683
[TBL] [Abstract][Full Text] [Related]
5. Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model.
Ma K; Xu L; Zhang H; Zhang S; Pu M; Jonas JB
Am J Ophthalmol; 2009 Feb; 147(2):326-31. PubMed ID: 18835468
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal profile of retinal ganglion cell damage assessed with blue-light confocal scanning laser ophthalmoscopy after ischaemic reperfusion injury.
Leung CK; Lindsey JD; Chen L; Liu Q; Weinreb RN
Br J Ophthalmol; 2009 Jul; 93(7):964-8. PubMed ID: 19224902
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal profile of retinal ganglion cell damage after optic nerve crush with blue-light confocal scanning laser ophthalmoscopy.
Leung CK; Lindsey JD; Crowston JG; Lijia C; Chiang S; Weinreb RN
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4898-902. PubMed ID: 18441315
[TBL] [Abstract][Full Text] [Related]
8. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection.
Levkovitch-Verbin H; Harris-Cerruti C; Groner Y; Wheeler LA; Schwartz M; Yoles E
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4169-74. PubMed ID: 11095611
[TBL] [Abstract][Full Text] [Related]
9. Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma.
Wheeler LA; Woldemussie E
Eur J Ophthalmol; 2001; 11 Suppl 2():S30-5. PubMed ID: 11592528
[TBL] [Abstract][Full Text] [Related]
10. Progressive damage along the optic nerve following induction of crush injury or rodent anterior ischemic optic neuropathy in transgenic mice.
Dratviman-Storobinsky O; Hasanreisoglu M; Offen D; Barhum Y; Weinberger D; Goldenberg-Cohen N
Mol Vis; 2008; 14():2171-9. PubMed ID: 19052651
[TBL] [Abstract][Full Text] [Related]
11. α-Crystallin protects RGC survival and inhibits microglial activation after optic nerve crush.
Wu N; Yu J; Chen S; Xu J; Ying X; Ye M; Li Y; Wang Y
Life Sci; 2014 Jan; 94(1):17-23. PubMed ID: 24220677
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Effects of Human Serum Albumin Nanoparticles Loaded With Brimonidine on Retinal Ganglion Cells in Optic Nerve Crush Model.
Kim KE; Jang I; Moon H; Kim YJ; Jeoung JW; Park KH; Kim H
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5641-9. PubMed ID: 26313300
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal in vivo imaging of retinal ganglion cells and retinal thickness changes following optic nerve injury in mice.
Chauhan BC; Stevens KT; Levesque JM; Nuschke AC; Sharpe GP; O'Leary N; Archibald ML; Wang X
PLoS One; 2012; 7(6):e40352. PubMed ID: 22768284
[TBL] [Abstract][Full Text] [Related]
14. From the lab to the clinic: activation of an alpha-2 agonist pathway is neuroprotective in models of retinal and optic nerve injury.
Wheeler LA; Lai R; Woldemussie E
Eur J Ophthalmol; 1999; 9 Suppl 1():S17-21. PubMed ID: 10230601
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush.
Mac Nair CE; Fernandes KA; Schlamp CL; Libby RT; Nickells RW
J Neuroinflammation; 2014 Nov; 11():194. PubMed ID: 25407441
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy.
Danylkova NO; Alcala SR; Pomeranz HD; McLoon LK
Exp Eye Res; 2007 Feb; 84(2):293-301. PubMed ID: 17113077
[TBL] [Abstract][Full Text] [Related]
17. Changes in Thy1 gene expression associated with damaged retinal ganglion cells.
Schlamp CL; Johnson EC; Li Y; Morrison JC; Nickells RW
Mol Vis; 2001 Aug; 7():192-201. PubMed ID: 11509915
[TBL] [Abstract][Full Text] [Related]
18. Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma.
Kalesnykas G; Oglesby EN; Zack DJ; Cone FE; Steinhart MR; Tian J; Pease ME; Quigley HA
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3847-57. PubMed ID: 22589442
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging and counting of rat retinal ganglion cells using a scanning laser ophthalmoscope.
Higashide T; Kawaguchi I; Ohkubo S; Takeda H; Sugiyama K
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2943-50. PubMed ID: 16799037
[TBL] [Abstract][Full Text] [Related]
20. Cyan fluorescent protein (CFP) expressing cells in the retina of Thy1-CFP transgenic mice before and after optic nerve injury.
Wang X; Archibald ML; Stevens K; Baldridge WH; Chauhan BC
Neurosci Lett; 2010 Jan; 468(2):110-4. PubMed ID: 19879331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
